MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that Mark Sieczkarek, president and chief executive officer, will present at the UBS Global Life Sciences Conference on Monday, September 21, 2009, at 4:30 p.m. ET. The conference will be held at the Grand Hyatt New York.
